Non-Small Cell Lung Cancer Market, By Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Large Cell Neuroendocrine Tumors), By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End User (Hospitals, Homecare, Specialty

Non-Small Cell Lung Cancer Market, By Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Large Cell Neuroendocrine Tumors), By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End User (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer that accounts for around 85% of all lung cancers. It is among the leading causes of cancer-related deaths worldwide. Global non-small cell lung cancer market growth is driven by factors like rising prevalence of smoking habits and environmental pollution, increasing research & development activities for advanced treatment options and growing demand for targeted and personalized medicines. However, high treatment costs hampers the market growth.

Market Dynamics:

Global non-small cell lung cancer market growth is driven by increasing prevalence of smoking across both developed and developing nations, growing environmental pollution levels and aging population. According to WHO, around 1.80 million new lung cancer cases are reported globally each year, majority of which are NSCLC. Advancements in targeted therapies and cancer treatment modalities offers opportunities for market players. However, high costs associated with targeted drugs and lack of awareness in low-income countries hampers the market growth. Moreover, risk of drug failure during trials also negatively impacts R&D activities.

Key features of the study:
  • This report provides in-depth analysis of the global non-small cell lung cancer market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global non-small cell lung cancer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include AstraZeneca, Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Celgene Corporation, Merck KGaA, Johnson & Johnson.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global non-small cell lung cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-small cell lung cancer market.
Detailed Segmentation-
  • By Type
  • Adenocarcinoma
  • Squamous Cell Carcinoma
  • Large Cell Carcinoma
  • Large Cell Neuroendocrine Tumors
  • Treatment
  • Chemotherapy
  • Targeted Therapy
  • Bevacizumab
  • Necitumumab
  • Ramucirumab
  • Immunotherapy
  • Nivolumab
  • Atezolizumab
  • Others
  • End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Hoffmann-La Roche Ltd
  • Honeywell International Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Celgene Corporation
  • Amgen Inc.
  • Johnson & Johnson
  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Treatment
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Non-Small Cell Lung Cancer Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Non-Small Cell Lung Cancer Market, By Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Adenocarcinoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Squamous Cell Carcinoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Large Cell Carcinoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Large Cell Neuroendocrine Tumors
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Non-Small Cell Lung Cancer Market, By Treatment, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Chemotherapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Targeted Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Bevacizumab (Avastin)
Necitumumab (Portrazza)
Ramucirumab (Cyramza)
Immunotherapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Nivolumab (Opdivo)
Atezolizumab (Tecentriq)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Non-Small Cell Lung Cancer Market, By End User, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospitals
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Home Care
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Specialty Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Non-Small Cell Lung Cancer Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
F. Hoffmann-La Roche Ltd
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Honeywell International Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
AstraZeneca PLC
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Bristol-Myers Squibb Company
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Eli Lilly and Company
Boehringer Ingelheim International GmbH
Celgene Corporation
Amgen Inc.
Johnson & Johnson
Gilead Sciences, Inc.
AbbVie Inc.
Astellas Pharma Inc.
Takeda Pharmaceutical Company Limited
Sanofi
Teva Pharmaceutical Industries Ltd.
Bayer AG
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. Section
References
Research Methodology
About Us and Sales Contact
*Browse 32 market data tables and 28 figures on Non-Small Cell Lung Cancer Market” - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings